Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndrome.

Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndrome.

Item
http://www.wikidata.org/entity/Q37046021
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapyTargeting the Mitotic Catastrophe Signaling Pathway in CancerMaximising the potential of AKT inhibitors as anti-cancer treatmentsDevelopment of synthetic lethality anticancer therapeutics.Selective anti-cancer agents as anti-aging drugsNew strategies in acute myelogenous leukemia: leukemogenesis and personalized medicine.Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasms.Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia.Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.Outlook on PI3K/AKT/mTOR inhibition in acute leukemia.Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy.Investigation of the Lipid Binding Properties of the Marburg Virus Matrix Protein VP40.Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.Perifosine enhances bevacizumab-induced apoptosis and therapeutic efficacy by targeting PI3K/AKT pathway in a glioblastoma heterotopic model.STK3 is a therapeutic target for a subset of acute myeloid leukemias.
P2860

Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndrome.

Item
http://www.wikidata.org/entity/Q37046021
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase I study of UCN-01 and pe ...... risk myelodysplastic syndrome.
@en
Phase I study of UCN-01 and pe ...... risk myelodysplastic syndrome.
@nl
type
label
Phase I study of UCN-01 and pe ...... risk myelodysplastic syndrome.
@en
Phase I study of UCN-01 and pe ...... risk myelodysplastic syndrome.
@nl
prefLabel
Phase I study of UCN-01 and pe ...... risk myelodysplastic syndrome.
@en
Phase I study of UCN-01 and pe ...... risk myelodysplastic syndrome.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
Phase I study of UCN-01 and pe ...... risk myelodysplastic syndrome.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P698
P932